Hemophilia B

Aristada recently received approval from the US Food and Drug Administration for a new and shorter dosing regimen, providing more options to patients and health care providers.

Aristada recently received approval from the US Food and Drug Administration for a new and shorter dosing regimen, providing more options to patients and health care providers.

The US Food and Drug Administration has expanded the approval of the Sapien 3 Transcatheter Heart Valve.

The US Food and Drug Administration has expanded the approval of the Sapien 3 Transcatheter Heart Valve.

The US Food and Drug Administration has expanded the approval of the Sapien 3 Transcatheter Heart Valve.

The FDA has approved a topical ocular formulation of a common antihistamine for the treatment of conjunctivitis.

The FDA has approved a topical ocular formulation of a common antihistamine for the treatment of conjunctivitis.

The FDA has approved a topical ocular formulation of a common antihistamine for the treatment of conjunctivitis.

The US Food and Drug Administration recently approved a new treatment option for patients with hemophilia B.

The US Food and Drug Administration recently approved a new treatment option for patients with hemophilia B.